Literature DB >> 10182886

Formulary limitations and the elderly: results from the Managed Care Outcomes Project.

S D Horn1, P D Sharkey, C Phillips-Harris.   

Abstract

OBJECTIVE: To examine whether restrictive formularies are associated with differences in healthcare resource utilization, including number of office visits, prescriptions, and hospitalizations, and whether this association varies by age. STUDY
DESIGN: Cross-sectional, longitudinal study. PATIENTS AND METHODS: Patients enrolled in one of six health maintenance organizations in six different states, three in the eastern and three in the western United States, were eligible for the study. Data from between 1309 and 3938 patients were available for analysis for each of the five diseases studied, for a total of 12,997 patients across all study diseases. Healthcare utilization by patients in the study included more than 99,000 office visits, 1000 hospitalizations, and 240,000 prescriptions. We used severity-adjusted prescription counts, prescription costs, office visit counts, and measures of inpatient hospital utilization to assess the effects of formulary limitations.
RESULTS: We found positive, significant associations between the independent variable formulary limitations in drug class and the dependent variables measuring resource utilization. These associations were sometimes significantly greater for elderly patients after controlling for severity of illness and other variables.
CONCLUSIONS: Common strategies for decreasing drug expenditures may be associated with higher severity-adjusted resource utilization. In specific areas, this association is more pronounced in the elderly.

Entities:  

Mesh:

Year:  1998        PMID: 10182886

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  3 in total

Review 1.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

2.  Improving the effectiveness of health care and public health: a multiscale complex systems analysis.

Authors:  Yaneer Bar-Yam
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

3.  Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

Authors:  Sebastian Schneeweiss; Malcolm Maclure; Bruce Carleton; Robert J Glynn; Jerry Avorn
Journal:  BMJ       Date:  2004-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.